Peter Bronsert

8.6k total citations · 1 hit paper
142 papers, 3.9k citations indexed

About

Peter Bronsert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Peter Bronsert has authored 142 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 41 papers in Surgery. Recurrent topics in Peter Bronsert's work include Pancreatic and Hepatic Oncology Research (39 papers), Cancer Cells and Metastasis (25 papers) and Cancer Genomics and Diagnostics (18 papers). Peter Bronsert is often cited by papers focused on Pancreatic and Hepatic Oncology Research (39 papers), Cancer Cells and Metastasis (25 papers) and Cancer Genomics and Diagnostics (18 papers). Peter Bronsert collaborates with scholars based in Germany, United States and Switzerland. Peter Bronsert's co-authors include Ulrich T. Hopt, Thomas Brabletz, Martin Werner, Ulrich F. Wellner, Jens Hoeppner, Tobias Keck, Simone Brabletz, Marc P. Stemmler, Oliver Schilling and Melanie Boerries and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Peter Bronsert

130 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer

2017 729 citations Melanie Boerries, Peter Bronsert et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Bronsert Germany	31	1.7k	1.4k	1.2k	896	807	142	3.9k
Jörg Hennenlotter Germany	36	1.0k 0.6×	1.8k 1.3×	1.3k 1.1×	827 0.9×	1.1k 1.4×	188	4.3k
Satoshi Nishizuka Japan	39	991 0.6×	3.1k 2.2×	760 0.6×	781 0.9×	976 1.2×	129	4.8k
Sarah Minner Germany	35	1.1k 0.6×	2.0k 1.4×	1.9k 1.6×	1.2k 1.3×	696 0.9×	127	4.2k
Wilma E. Mesker Netherlands	40	2.5k 1.5×	2.2k 1.5×	723 0.6×	1.3k 1.4×	576 0.7×	156	5.5k
Benjamin Esterni France	32	2.2k 1.3×	1.4k 1.0×	683 0.6×	1.0k 1.1×	512 0.6×	75	4.4k
Jin Gu China	30	1.5k 0.9×	1.1k 0.8×	552 0.5×	665 0.7×	652 0.8×	154	3.0k
Daniela E. Aust Germany	37	2.3k 1.3×	1.4k 1.0×	869 0.7×	866 1.0×	1.3k 1.6×	173	4.7k
Giannoula Klement United States	29	1.7k 1.0×	2.3k 1.6×	666 0.5×	1.2k 1.3×	674 0.8×	67	4.9k
Georg Schäfer Austria	36	587 0.3×	1.6k 1.1×	1.2k 1.0×	717 0.8×	408 0.5×	91	3.3k

Countries citing papers authored by Peter Bronsert

Since Specialization

Citations

This map shows the geographic impact of Peter Bronsert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bronsert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bronsert more than expected).

Fields of papers citing papers by Peter Bronsert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bronsert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bronsert. The network helps show where Peter Bronsert may publish in the future.

Co-authorship network of co-authors of Peter Bronsert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bronsert. A scholar is included among the top collaborators of Peter Bronsert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bronsert. Peter Bronsert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Waibel, P, Tobias Fechter, Michael Mix, et al.. (2025). Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2023–2033. 3 indexed citations

Antolini, Laura, Jurij Kiefer, Peter Bronsert, et al.. (2025). Intratumoral heterogeneity of cancer driver genomic alterations in myxoid liposarcomas. Cancer. 131(12). e35937–e35937. 1 indexed citations

Passlick, Bernward, et al.. (2025). The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer. Cancers. 17(7). 1142–1142.

Bronsert, Peter, Oliver Schilling, Kim C. Honselmann, et al.. (2024). Postoperative pancreatic fistula risk assessment using digital pathology based analyses at the parenchymal resection margin of the pancreas – Results from the randomized multicenter RECOPANC trial. HPB. 27(3). 393–401.

Enderle-Ammour, Kathrin, Marc Christian Metzger, Philipp Poxleitner, et al.. (2024). AI-Based Detection of Oral Squamous Cell Carcinoma with Raman Histology. Cancers. 16(4). 689–689. 3 indexed citations

Bolm, Louisa, Monika Klinkhammer‐Schalke, Sylke Ruth Zeißig, et al.. (2024). When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group. Cancers. 16(2). 440–440. 1 indexed citations

Cosenza‐Contreras, Miguel, Melanie Christine Föll, Bálint András Barta, et al.. (2023). Proteome alterations in human autopsy tissues in relation to time after death. Cellular and Molecular Life Sciences. 80(5). 117–117. 17 indexed citations

Thomsen, Andreas, Peter Bronsert, Oliver Schilling, et al.. (2023). Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer. Frontiers in Oncology. 13. 1275222–1275222. 1 indexed citations

Bronsert, Peter, et al.. (2023). Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas. Life. 13(7). 1570–1570. 8 indexed citations

10.

Krafft, Christoph, Jürgen Popp, Peter Bronsert, & Arkadiusz Miernik. (2023). Raman Spectroscopic Imaging of Human Bladder Resectates towards Intraoperative Cancer Assessment. Cancers. 15(7). 2162–2162. 14 indexed citations

11.

Rühle, Alexander, Ramon Lopez Perez, Andreas Thomsen, et al.. (2022). Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 23(14). 7689–7689. 3 indexed citations

12.

Braun, Rüdiger, Monika Klinkhammer‐Schalke, Sylke Ruth Zeißig, et al.. (2022). Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma—Results from the German Cancer Registry Group. Cancers. 14(16). 3946–3946. 10 indexed citations

13.

Boettler, Tobias, Benedikt Csernalabics, Henrike Salié, et al.. (2022). SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis. Journal of Hepatology. 77(3). 653–659. 92 indexed citations

14.

Bronsert, Peter, Andrew Fuller, Andrew Filby, et al.. (2021). Multiple Immunostainings with Different Epitope Retrievals—The FOLGAS Protocol. International Journal of Molecular Sciences. 23(1). 223–223. 4 indexed citations

15.

Petrova, Ekaterina, Rüdiger Braun, Kim C. Honselmann, et al.. (2021). Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group. Cancers. 13(23). 6121–6121. 11 indexed citations

16.

Bolm, Louisa, Katharina Mueller, Ekaterina Petrova, et al.. (2020). Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients—Proposal of a New Simplified Borderline Resectability Definition. Cancers. 12(4). 882–882. 7 indexed citations

17.

Föll, Melanie Christine, Thomas Wollmann, Martin Werner, et al.. (2019). Accessible and reproducible mass spectrometry imaging data analysis in Galaxy. GigaScience. 8(12). 27 indexed citations

18.

Bronsert, Peter, Sabine Riethdorf, Bartosz Rylski, et al.. (2018). Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases. Scientific Reports. 8(1). 8751–8751. 17 indexed citations

19.

Metzger, Eric, Sylvia Urban, Dominica Willmann, et al.. (2017). KDM4 Inhibition Targets Breast Cancer Stem–like Cells. Cancer Research. 77(21). 5900–5912. 73 indexed citations

20.

Wellner, Ulrich F., Tobias Krauß, Ágnes Csanádi, et al.. (2016). Mesopancreatic Stromal Clearance Defines Curative Resection of Pancreatic Head Cancer and Can Be Predicted Preoperatively by Radiologic Parameters. Medicine. 95(3). e2529–e2529. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact